Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.23
-0.27 (-4.15%)
At close: Dec 5, 2025, 4:00 PM EST
6.35
+0.12 (1.93%)
After-hours: Dec 5, 2025, 7:07 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
Novel Therapies
675.00K
Log In
Novel Therapies Growth
-29.02%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
United States
675.00K
Log In
United States Growth
-29.02%
Log In